Canertinib
Cat.No:IC1740 Solarbio
CAS:267243-28-7
Storage:Powder:2-8℃,2 years
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Angiogenesis >
CanertinibCAS:267243-28-7
Storage:Powder:2-8℃,2 years
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
CAS | 267243-28-7 |
Name | Canertinib |
Molecular Formula | C24H25ClFN5O3 |
Molecular Weight | 485.94 |
Solubility | Soluble in DMSO ≥0.1mg/mL(Need ultrasonic) |
Purity | ≥98% |
Appearance | Light yellow to yellow Solid |
Storage | Powder:2-8℃,2 years |
EC | EINECS 1308068-626-2 |
MDL | MFCD09837878 |
SMILES | O=C(NC1=C(C=C2C(C(NC3=CC=C(C(Cl)=C3)F)=NC=N2)=C1)OCCCN4CCOCC4)C=C |
Target Point | EGFR;ErbB2 |
Passage | Angiogenesis; Protein Tyrosine Kinase/RTK; JAK/STAT Signaling |
Background | Canertinib is a potent, irreversible EGFR inhibitor. |
Biological Activity | Canertinib 是有效地,不可逆的 EGFR 抑制剂;抑制细胞 EGFR 和 ErbB2 自身磷酸化的 IC50 值分别为7.4和9 nM[1-2]。 |
IC50 | EGFR:7.4nM ErbB2:9nM [1-2] |
In Vitro | Canertinib以剂量依赖性方式显著抑制培养的黑素瘤细胞RaH3和RaH5的生长。 IC50约为0.8μM,并且5μM两种细胞系在治疗72小时内完全生长停滞。用1μMCanertinib孵育指数生长的RaH3和RaH5在处理24小时内将细胞积聚在细胞周期的G1期而不诱导细胞凋亡。 1μMCanertinib抑制ErbB1-3受体磷酸化,伴随着两种细胞系中Akt-,Erk1/2-和Stat3活性的降低[2]。 |
In Vivo | Canertinib显示出优异的体内抗肿瘤活性,使口服给药后A431异种移植物的生长延迟超过50天[1]。通过ip注射40mg/kg /天的canertinib显著抑制裸鼠中人恶性黑素瘤异种移植物RaH3和RaH5的生长(图4)。对黑素瘤异种移植物的抗增殖作用在治疗后4天内已经可见,并且在整个治疗期间进一步增加,如通过肿瘤体积的差异所观察到的,在治疗的18天内达到统计学显著性[2]。 |
Cell Experiment | 用递增浓度(0-10μM)的Canertinib处理RaH3和RaH5细胞72小时。将细胞悬浮在缓冲液中并计数[2]。 |
Animal Experiment | 小鼠:当肿瘤显示可靠的生长时,Canertinib治疗开始。将小鼠随机分为对照组和治疗组。在canertinib处理的RaH3组(n = 4)和RaH5组(n = 7)中,每只小鼠每周5天在0.1ml 0.15M NaCl中腹膜内注射1.2mg卡培替尼(40mg/kg /天)。对照RaH3(n = 3)和RaH5(n = 7)小鼠仅根据相同的方案接受ip注射载体。在治疗期结束时,通过颈椎脱位处死小鼠,然后取出肿瘤并称重[2]。 |
Data Literature Source | [1]. Smaill JB,et al. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions. J Med Chem. 2000 Apr 6;43(7):1380-97. [2]. Djerf Severinsson EA,et al. The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo. Biochem Biophys Res Commun. 2011 Oct 28;414(3):563-8 |
Unit | Bottle |
Specification | 10mg 50mg |
是有效地,不可逆的 EGFR 抑制剂。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.